Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Keratinocyte Skin Cancer
Interventions
DEVICE

Nevisense

The Nevisense system is based on Electrical Impedance Spectroscopy (EIS). EIS is a measure of the overall resistance within a skin tissue, at alternating currents of various frequencies. Since skin tissues have different electrical properties depending on cell structure and medical conditions, the resulting electrical impedance spectra will reflect the properties of the skin tissue.

Trial Locations (1)

Unknown

RECRUITING

CentroDerm, Wuppertal

All Listed Sponsors
lead

SciBase AB

OTHER